Home / 6535.TWO : TWO

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does 6535.TWO make money? Does 6535.TWO have pricing power? What's the Earnings Whisper? Will 6535.TWO profit more as the business scales? What is 6535.TWO's management track record? Is 6535.TWO's current price justified?

Lumosa Therapeutics Co., Ltd.

TWD 75.1 -$112.90 (-60.05%)

TWO · 16 Sep 2026 03:39 UTC

Previous Close

TWD 75.2

Day Range

TWD 75.1TWD 76

Year Range

TWD 73.7TWD 329.5

Market Cap

12.58B

AVG Volume

263.91K

Trailing/Forward PE

-33.68/-

PEG ratio

2.67

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

Taipei Exchange

Revenue (TWD) · TTM

6535.TWO Revenue (TWD) · TTM by quarter
Period	Revenue (TWD) · TTM
26 Q2	34.37M
26 Q1	31.42M
25 Q4	35.83M
25 Q3	42.59M
25 Q2	37.25M
25 Q1	43.59M
24 Q4	39.15M
24 Q3	37.81M
24 Q2	47.71M
24 Q1	53.4M

Net Income (TWD) · TTM

6535.TWO Net Income (TWD) · TTM by quarter
Period	Net Income (TWD) · TTM
26 Q2	-370.06M
26 Q1	-356.04M
25 Q4	-340.54M
25 Q3	-433.41M
25 Q2	-628.59M
25 Q1	-413.35M
24 Q4	-424.78M
24 Q3	-388.8M
24 Q2	-280.72M
24 Q1	-499M

Operating Income (TWD) · TTM

6535.TWO Operating Income (TWD) · TTM by quarter
Period	Operating Income (TWD) · TTM
26 Q2	-303.39M
26 Q1	-293.59M
25 Q4	-333.51M
25 Q3	-405.34M
25 Q2	-420.75M
25 Q1	-382.65M
24 Q4	-356.94M
24 Q3	-349.23M
24 Q2	-348.52M
24 Q1	-383.75M

EBITDA (TWD) · TTM

6535.TWO EBITDA (TWD) · TTM by quarter
Period	EBITDA (TWD) · TTM
26 Q2	-254.62M
26 Q1	-283.43M
25 Q4	-322.23M
25 Q3	-432.34M
25 Q2	-630.21M
25 Q1	-415.33M
24 Q4	-428.24M
24 Q3	-390.17M
24 Q2	-276.89M
24 Q1	-491.62M

Cash Flows (TWD) · TTM

6535.TWO Cash Flows (TWD) · TTM by quarter
Period	Cash Flows (TWD) · TTM
26 Q2	-257.63M
26 Q1	-331.98M
25 Q4	-361.16M
25 Q3	-418.97M
25 Q2	-420.05M
25 Q1	-298.13M
24 Q4	-296.78M
24 Q3	-273.46M
24 Q2	-296.85M
24 Q1	-231.78M

EPS (TWD) · TTM

6535.TWO EPS (TWD) · TTM by quarter
Period	EPS (TWD) · TTM
26 Q2	-2.23
26 Q1	-2.15
25 Q4	-2.06
25 Q3	-2.62
25 Q2	-3.82
25 Q1	-2.52
24 Q4	-2.6
24 Q3	-2.39
24 Q2	-1.73
24 Q1	-3.06

Expenses (TWD) · TTM

6535.TWO Expenses (TWD) · TTM by quarter
Period	Expenses (TWD) · TTM
26 Q2	320.22M
26 Q1	311.33M
25 Q4	356.02M
25 Q3	429.07M
25 Q2	439.75M
25 Q1	404.62M
24 Q4	375.11M
24 Q3	376.05M
24 Q2	396.99M
24 Q1	334.19M

Shares Outstanding (TWD) · TTM

6535.TWO Shares Outstanding (TWD) · TTM by quarter
Period	Shares Outstanding (TWD) · TTM
26 Q2	-7.61M
26 Q1	41.58M
25 Q4	35.29M
25 Q3	27.29M
25 Q2	20.87M
25 Q1	-36.13M
24 Q4	-37.96M
24 Q3	-35.11M
24 Q2	-22.21M
24 Q1	-14.4M

PE Ratio

6535.TWO PE Ratio by quarter
Period	PE Ratio
Jun 22	57.93
Jun 22	57.36
Jun 22	57.12
Jun 22	55.08
May 22	54.59
May 22	54.76
May 22	54.59
May 22	56.87
Apr 22	58.01
Apr 22	64.1
Apr 22	57.04
Apr 22	56.3
Apr 22	56.55
Mar 22	15.81
Mar 22	15.81
Mar 22	15.7
Mar 22	16.71
Feb 22	17.3
Feb 22	17.42
Feb 22	17.57
Jan 22	17.44
Jan 22	17.01
Jan 22	16.95
Jan 22	17.44
Dec 21	17.95

Free Cash Flow Yield

6535.TWO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-2.66%
Sep 26	-2.65%
Sep 26	-2.51%
Aug 26	-2.54%
Aug 26	-2.47%
Aug 26	-2.32%
Aug 26	-2.19%
Jul 26	-2.3%
Jul 26	-2.22%
Jul 26	-2.21%
Jul 26	-1.99%
Jul 26	-1.86%
Jun 26	-2.25%
Jun 26	-2.12%
Jun 26	-2.04%
Jun 26	-1.9%
May 26	-1.79%
May 26	-1.71%
May 26	-1.66%
May 26	-1.61%
Apr 26	-1.44%
Apr 26	-1.75%
Apr 26	-1.67%
Apr 26	-1.57%
Apr 26	-1.53%
Mar 26	-1.77%
Mar 26	-1.76%
Mar 26	-1.69%
Mar 26	-1.63%
Feb 26	-1.48%
Feb 26	-1.43%
Feb 26	-1.32%
Jan 26	-1.46%
Jan 26	-1.42%
Jan 26	-1.38%
Jan 26	-1.36%
Jan 26	-1.36%
Dec 25	-1.33%
Dec 25	-1.38%
Dec 25	-1.34%
Dec 25	-1.32%
Nov 25	-1.16%
Nov 25	-1.4%
Nov 25	-1.34%
Nov 25	-1.26%
Oct 25	-1.2%
Oct 25	-0.91%
Oct 25	-0.87%
Oct 25	-0.93%
Oct 25	-0.86%
Sep 25	-0.63%
Sep 25	-0.58%
Sep 25	-0.63%
Sep 25	-0.74%
Aug 25	-0.94%
Aug 25	-0.92%
Aug 25	-1.06%
Aug 25	-1.27%
Aug 25	-1.42%
Jul 25	-1.33%
Jul 25	-1.31%
Jul 25	-1.29%
Jul 25	-1.27%
Jun 25	-1.19%
Jun 25	-1.19%
Jun 25	-1.1%
Jun 25	-1.03%
May 25	-1.11%
May 25	-1.1%
May 25	-1.23%
May 25	-1.15%
May 25	-1.08%
Apr 25	-1.15%
Apr 25	-1.15%
Apr 25	-1.17%
Apr 25	-1.01%
Mar 25	-0.89%
Mar 25	-0.8%
Mar 25	-0.85%
Mar 25	-0.74%
Feb 25	-0.74%
Feb 25	-0.71%
Feb 25	-0.68%
Feb 25	-0.65%
Jan 25	-0.71%
Jan 25	-0.71%
Jan 25	-0.67%
Jan 25	-0.71%
Dec 24	-0.87%
Dec 24	-0.92%
Dec 24	-0.97%
Dec 24	-0.84%
Nov 24	-0.5%
Nov 24	-0.51%
Nov 24	-0.53%
Nov 24	-0.52%
Nov 24	-0.5%
Oct 24	-0.47%
Oct 24	-0.57%
Oct 24	-0.59%

Price to Sales

6535.TWO Price to Sales by quarter
Period	Price to Sales
Sep 26	397.88
Sep 26	398.94
Sep 26	421.69
Aug 26	415.87
Aug 26	428.04
Aug 26	455.55
Aug 26	482.01
Jul 26	460.32
Jul 26	476.72
Jul 26	477.25
Jul 26	531.74
Jul 26	568.78
Jun 26	447.54
Jun 26	475.23
Jun 26	493.68
Jun 26	530.59
May 26	562.89
May 26	588.27
May 26	609.03
May 26	627.48
Apr 26	701.31
Apr 26	576.73
Apr 26	604.41
Apr 26	641.33
Apr 26	657.47
Mar 26	556.6
Mar 26	558.52
Mar 26	581.63
Mar 26	602.82
Feb 26	666.38
Feb 26	689.49
Feb 26	745.34
Jan 26	676
Jan 26	691.41
Jan 26	714.52
Jan 26	724.15
Jan 26	724.15
Dec 25	849.93
Dec 25	818.7
Dec 25	841
Dec 25	856.62
Nov 25	970.39
Nov 25	803.08
Nov 25	843.24
Nov 25	896.77
Oct 25	936.93
Oct 25	1244.78
Oct 25	1293.85
Oct 25	1209.08
Oct 25	1311.7
Sep 25	1085.12
Sep 25	1183.77
Sep 25	1083.22
Sep 25	918.18
Aug 25	724.68
Aug 25	747.44
Aug 25	646.9
Aug 25	538.77
Aug 25	481.85
Jul 25	514.1
Jul 25	521.69
Jul 25	531.18
Jul 25	536.87
Jun 25	637.45
Jun 25	639.56
Jun 25	692.15
Jun 25	734.23
May 25	681.63
May 25	690.05
May 25	618.52
May 25	660.6
May 25	700.57
Apr 25	660.6
Apr 25	656.39
Apr 25	645.87
Apr 25	746.85
Mar 25	813.94
Mar 25	900.07
Mar 25	848.39
Mar 25	979.74
Feb 25	979.74
Feb 25	1012.04
Feb 25	1059.41
Feb 25	1113.24
Jan 25	1020.65
Jan 25	1022.81
Jan 25	1087.4
Jan 25	1016.35
Dec 24	714.11
Dec 24	676.26
Dec 24	643.56
Dec 24	736.48
Nov 24	1242.39
Nov 24	1214.85
Nov 24	1164.95
Nov 24	1204.53
Nov 24	1244.11
Oct 24	1316.38
Oct 24	1094.4
Oct 24	1049.66

EV/EBITDA

6535.TWO EV/EBITDA by quarter
Period	EV/EBITDA
Jun 22	31.71
Jun 22	31.29
Jun 22	31.11
Jun 22	29.61
May 22	29.25
May 22	29.37
May 22	29.25
May 22	30.93
Apr 22	31.77
Apr 22	36.28
Apr 22	31.05
Apr 22	30.51
Apr 22	30.69
Mar 22	10.76
Mar 22	10.76
Mar 22	10.66
Mar 22	11.57
Feb 22	12.12
Feb 22	12.22
Feb 22	12.36
Jan 22	12.24
Jan 22	11.85
Jan 22	11.79
Jan 22	12.24
Dec 21	12.71

Price to Book

6535.TWO Price to Book by quarter
Period	Price to Book
Sep 26	8.91
Sep 26	8.93
Sep 26	9.44
Aug 26	9.31
Aug 26	9.58
Aug 26	10.2
Aug 26	10.79
Jul 26	10.3
Jul 26	10.67
Jul 26	10.68
Jul 26	11.9
Jul 26	12.73
Jun 26	10.56
Jun 26	11.21
Jun 26	11.64
Jun 26	12.51
May 26	13.28
May 26	13.87
May 26	14.36
May 26	14.8
Apr 26	16.54
Apr 26	13.6
Apr 26	14.26
Apr 26	15.13
Apr 26	15.51
Mar 26	14.79
Mar 26	14.84
Mar 26	15.46
Mar 26	16.02
Feb 26	17.71
Feb 26	18.32
Feb 26	19.81
Jan 26	17.96
Jan 26	18.37
Jan 26	18.99
Jan 26	19.24
Jan 26	19.24
Dec 25	19.43
Dec 25	18.72
Dec 25	19.23
Dec 25	19.59
Nov 25	22.19
Nov 25	18.36
Nov 25	19.28
Nov 25	20.51
Oct 25	21.42
Oct 25	28.46
Oct 25	29.59
Oct 25	27.65
Oct 25	29.99
Sep 25	25.87
Sep 25	28.22
Sep 25	25.82
Sep 25	21.89
Aug 25	17.28
Aug 25	17.82
Aug 25	15.42
Aug 25	12.84
Aug 25	11.49
Jul 25	12.26
Jul 25	12.44
Jul 25	12.66
Jul 25	12.8
Jun 25	12.95
Jun 25	12.99
Jun 25	14.06
Jun 25	14.91
May 25	13.85
May 25	14.02
May 25	12.56
May 25	13.42
May 25	14.23
Apr 25	13.42
Apr 25	13.33
Apr 25	13.12
Apr 25	15.17
Mar 25	26.19
Mar 25	28.96
Mar 25	27.3
Mar 25	31.52
Feb 25	31.52
Feb 25	32.56
Feb 25	34.09
Feb 25	35.82
Jan 25	32.84
Jan 25	32.91
Jan 25	34.99
Jan 25	32.7
Dec 24	24.47
Dec 24	23.17
Dec 24	22.05
Dec 24	25.23
Nov 24	42.57
Nov 24	41.62
Nov 24	39.91
Nov 24	41.27
Nov 24	42.63
Oct 24	45.1
Oct 24	37.5
Oct 24	35.96

No video analysis for this stock yet. Request one from our team.

AI Analysis

Lumosa Therapeutics Co., Ltd.

Video analysis: 6535.TWO

Similar companies